Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) berberine derivatives. 2016

Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
Department of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China.

A series of 9-O-(lipophilic group substituted) berberine derivatives were synthesized and evaluated for their cytotoxicity and hypoglycemic activity against HepG2 cells. All the results indicated that most of the synthesized compounds exhibited lower cytotoxicity and a certain degree of hypoglycemic activity. Especially the compounds 5g and 5h displayed dramatically increased hypoglycemic activity compared with berberine, and the cytotoxicity maintained or even lower than berberine, indicating that they are potential candidates for new anti-type 2 diabetes mellitus drugs.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001599 Berberine An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal. Umbellatine
D013057 Spectrum Analysis The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Spectroscopy,Analysis, Spectrum,Spectrometry
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell

Related Publications

Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
May 2019, International journal of molecular sciences,
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
January 2013, Bioorganic & medicinal chemistry letters,
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
January 2018, Anti-cancer agents in medicinal chemistry,
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
January 2020, Beilstein journal of organic chemistry,
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
February 2020, Molecules (Basel, Switzerland),
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
January 2015, Indian journal of pharmaceutical sciences,
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
December 2022, Pharmaceutics,
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
April 2011, European journal of medicinal chemistry,
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
August 2001, Yao xue xue bao = Acta pharmaceutica Sinica,
Shanshan Zhang, and Xiaohong Wang, and Weicheng Yin, and Zhenbao Liu, and Mi Zhou, and Daipeng Xiao, and Yanfei Liu, and Dongming Peng
July 2009, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!